Topics

"Outcomes of Surgical Resection After Induction Treatment in Non-Small Cell Lung Cancer (SRaIT)" Drugs and Medication Database

05:41 EST 29th February 2020 | BioPortfolio

Here are the most relevant "Outcomes of Surgical Resection After Induction Treatment in Non-Small Cell Lung Cancer (SRaIT)" Drugs and Medications that we have found in our database.

More Information about "Outcomes of Surgical Resection After Induction Treatment in Non-Small Cell Lung Cancer (SRaIT)" on BioPortfolio

We have published hundreds of Outcomes of Surgical Resection After Induction Treatment in Non-Small Cell Lung Cancer (SRaIT) news stories on BioPortfolio along with dozens of Outcomes of Surgical Resection After Induction Treatment in Non-Small Cell Lung Cancer (SRaIT) Clinical Trials and PubMed Articles about Outcomes of Surgical Resection After Induction Treatment in Non-Small Cell Lung Cancer (SRaIT) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Outcomes of Surgical Resection After Induction Treatment in Non-Small Cell Lung Cancer (SRaIT) Companies in our database. You can also find out about relevant Outcomes of Surgical Resection After Induction Treatment in Non-Small Cell Lung Cancer (SRaIT) Drugs and Medications on this site too.

Showing "Outcomes Surgical Resection After Induction Treatment Small Cell" Drugs and Medications 1–25 of 33

Probably Relevant

Sylatron [merck sharp & dohme corp.]

These highlights do not include all the information needed to use SYLATRON safely and effectively. See full prescribing information for SYLATRON. SYLATRON™ (peginterferon alfa-2b) for injection, for subcutaneous use Initial U.S. Approval: 2011

Possibly Relevant

Entereg [merck sharp & dohme corp.]

These highlights do not include all the information needed to use ENTEREG safely and effectively. See full prescribing information for ENTEREG. ENTEREG (alvimopan) capsules, for oral use Initial U.S. Approval: 2008

Epirubicin hydrochloride [sagent pharmaceuticals]

These highlights do not include all the information needed to use EPIRUBICIN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for EPIRUBICIN HYDROCHLORIDE INJECTION. Epirubicin Hydrochloride Injection Initial U.S. Approval:

Glycine [hospira, inc.]

1.5% GLYCINE IRRIGATION, USP

Sorbitol-mannitol [hospira, inc.]

SORBITOL-MANNITOL IRRIGATION

Intron a [merck sharp & dohme corp.]

INTRON A Interferon alfa-2b, recombinant

Gliadel [arbor pharmaceuticals]

These highlights do not include all the information needed to use GLIADEL WAFER safely and effectively. See full prescribing information for GLIADEL WAFER. GLIADEL WAFER (carmustine implant), for intracranial useInitial U.S. Approval: 1996

Gleolan [nx development corp]

These highlights do not include all the information needed to use GLEOLAN safely and effectively. See full prescribing information for GLEOLAN. GLEOLAN™ [aminolevulinic acid hydrochloride (ALA HCl)] for oral solutionInitial U.S. Approval: [1999]

Glycine [b. braun medical inc.]

1.5% Glycine Irrigation USP

Temodar [physicians total care, inc.]

These highlights do not include all the information needed to use TEMODAR safely and effectively. See full prescribing information for TEMODAR. TEMODAR (temozolomide) CapsulesTEMODAR (temozolomide) for Injection administered via intravenous infusionInitia

Glycine [b. braun medical inc.]

1.5% Glycine Irrigation USP

Mannitol [b. braun medical inc.]

5% Mannitol Irrigation

Temozolomide [avpak]

Temozolomide Capsules These highlights do not include all the information needed to use TEMOZOLOMIDE CAPSULES safely and effectively. See full prescribing information for TEMOZOLOMIDE CAPSULES. TEMOZOLOMIDE capsules for oral use Initial U.S. Approval: 199

Valstar [endo pharmaceuticals solutions inc.]

These highlights do not include all the information needed to use VALSTAR safely and effectively. See full prescribing information for VALSTAR. VALSTAR(valrubicin) solution, for intravesical use Initial U.S. Approval:  1981

Mannitol [american regent, inc.]

MANNITOL INJECTION, USP 25% CONCENTRATION

Unituxin [united therapeutics corp.]

These highlights do not include all the information needed to use UNITUXIN safely and effectively. See Full Prescribing Information for UNITUXIN. UNITUXIN (dinutuximab) injection, for intravenous use Initial U.S. Approval: 2015

Mannitol [fresenius kabi usa, llc]

Mannitol Injection USP

Temozolomide [roxane laboratories, inc.]

These highlights do not include all the information needed to use TEMOZOLOMIDE Capsules safely and effectively. See full prescribing information for TEMOZOLOMIDE Capsules. TEMOZOLOMIDE (tem-oh-ZOHL-oh-mide) capsules, for oral use Initial U.S. Approval: 19

Iopidine [alcon laboratories, inc.]

IOPIDINE* 1%(apraclonidine hydrochloride ophthalmic solution) 1% as baseSterile

Choline c 11 [ucsf radiopharmaceutical facility]

These highlights do not include all the information needed to use CHOLINE C 11 INJECTION safely and effectively. See full prescribing information for CHOLINE C 11 INJECTION . Choline C 11 Injection , for intravenous use Initial U.S. Approval: 2012

Choline c 11 [washington university school of medicine]

These highlights do not include all the information needed to use CHOLINE C11 INJECTION safely and effectively. See full prescribing information for CHOLINE C11 INJECTION . Choline C 11 injection, for intravenous use Initial U.S. Approval: 2012

Choline c 11 [mayo clinic]

These highlights do not include all the information needed to use Choline C 11 Injection   safely and effectively. See full prescribing information for   Choline C 11 Injection .       Choline   C 11 Injection ,   for intravenous use Initial U.S.

Formaldehyde [rochester pharmaceuticals]

NA

Ifosfamide [fresenius kabi usa, llc]

Ifosfamide for Injection USP

Ibuprofen [lake erie medical & surgical supply dba quality care products llc]

Ibuprofen Tablets, USP



Quick Search